GDS Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2M Buy
285,219
+64,171
+29% +$4.28M 0.91% 49
2026
Q1
$13.9M Buy
221,048
+18,086
+9% +$1.26M 0.83% 52
2025
Q4
$13.5M Buy
202,962
+2,510
+1% +$162K 0.84% 46
2025
Q3
$13.5M Buy
200,452
+11,134
+6% +$881K 0.89% 47
2025
Q2
$16.5M Buy
189,318
+14,607
+8% +$1.14M 1.21% 35
2025
Q1
$11.9M Buy
174,711
+14,714
+9% +$1.2M 1.02% 39
2024
Q4
$12.4M Buy
159,997
+24,182
+18% +$1.79M 1.13% 38
2024
Q3
$9.11M Buy
135,815
+81,045
+148% +$6.66M 0.89% 43
2024
Q2
$6.21M Buy
54,770
+16,128
+42% +$2.04M 0.68% 54
2024
Q1
$5.36M Buy
+38,642
New +$4.86M 0.63% 55

Other funds holding DXCM

GDS Wealth Management's DXCM Position: Q2 2026 in Review

GDS Wealth Management increased its DexCom (DXCM) stake by 29% in Q2 2026, buying an estimated $4.28M and bringing the position to 285,219 shares worth $19.2M. The position accounts for 0.91% of the portfolio, ranked #49.

GDS Wealth Management first reported a position in DXCM in Q1 2024 and has held it in 10 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • GDS Wealth Management held 285,219 shares of DexCom worth $19.2M as of Q2 2026.
  • GDS Wealth Management bought 64,171 DexCom shares in Q2 2026, an estimated $4.28M.
  • DexCom made up 0.91% of GDS Wealth Management's portfolio in Q2 2026, its #49 holding.
  • GDS Wealth Management first reported a position in DexCom in Q1 2024 and has held it in 10 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on GDS Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.